Showing results (841-850 of 2,890) with videos related to
Sort By:
Pageof 289
JACC. Cardiovascular Interventions|April 20, 2010
The clinical impact of routine angiographic follow-up in randomized trials of drug-eluting stents: a critical assessment of "oculostenotic" reintervention in patients with intermediate lesionsTakahiro Uchida, Jeffrey Popma, Gregg W Stone, et al.JACC. Cardiovascular Interventions|July 16, 2010
Plaque distribution patterns in distal left main coronary artery to predict outcomes after stent implantationCorrado Tamburino, Piera Capranzano, Davide Capodanno, et al.JACC. Cardiovascular Interventions|July 16, 2010
Antithrombotic strategy in non-ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention: insights from the ACTION (Acute Coronary Treatment and Intervention Outcomes Network) RegistryRenato D Lopes, Eric D Peterson, Anita Y Chen, et al.JACC. Cardiovascular Interventions|July 24, 2010
The index of microcirculatory resistance measured acutely predicts the extent and severity of myocardial infarction in patients with ST-segment elevation myocardial infarctionRoss McGeoch, Stuart Watkins, Colin Berry, et al.JACC. Cardiovascular Interventions|July 24, 2010
Carriage of cytochrome 2C19 polymorphism is associated with risk of high post-treatment platelet reactivity on high maintenance-dose clopidogrel of 150 mg/day: results of the ACCEL-DOUBLE (Accelerated Platelet Inhibition by a Double Dose of Clopidogrel According to Gene Polymorphism) studyYoung-Hoon Jeong, In-Suk Kim, Yongwhi Park, et al.JACC. Cardiovascular Interventions|August 21, 2010
Outcomes of percutaneous coronary intervention in intermediate coronary artery disease: fractional flow reserve-guided versus intravascular ultrasound-guidedChang-Wook Nam, Hyuck-Jun Yoon, Yun-Kyeong Cho, et al.JACC. Cardiovascular Interventions|August 21, 2010
Retroperitoneal hematoma after percutaneous coronary intervention: prevalence, risk factors, management, outcomes, and predictors of mortality: a report from the BMC2 (Blue Cross Blue Shield of Michigan Cardiovascular Consortium) registrySanti Trimarchi, Dean E Smith, David Share, et al.JACC. Cardiovascular Interventions|October 23, 2010
Improved late clinical safety with zotarolimus-eluting stents compared with paclitaxel-eluting stents in patients with de novo coronary lesions: 3-year follow-up from the ENDEAVOR IV (Randomized Comparison of Zotarolimus- and Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease) trialMartin B Leon, Eugenia Nikolsky, Donald E Cutlip, et al.JACC. Cardiovascular Interventions|October 23, 2010
The unrestricted use of sirolimus- and paclitaxel-eluting stents results in better clinical outcomes during 6-year follow-up than bare-metal stents: an analysis of the RESEARCH (Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated At Rotterdam Cardiology Hospital) registriesCihan Simsek, Michael Magro, Eric Boersma, et al.JACC. Cardiovascular Interventions|October 23, 2010
Anatomic and technical predictors of stent malposition during implantation for vascular obstruction in patients with congenital and acquired heart diseaseJeffery Meadows, David Teitel, Phillip MoorePageof 289